Immunohistochemical analysis of biopsy specimens is an easy and safe method of estimating tumour biological characteristics, thus enabling individualised treatment strategies.
Identification of molecular biological prognostic factors would be of great value for more accurately classification of ovarian carcinomas into subtypes with a different clinical outcome, thereby possibly also enabling individualised treatment strategies (Crijns et al, 2006a).
The diagram illustrated in Figure 2 helped to symbolise the central, inclusive role for the student in the patient-student-preceptor triad and how this discrete teaching micro-environment would enable highly personalised and individualised patient-centred learning.
Continuing study of the Chernobyl-related tumours should allow continuing correlation of molecular biological changes with tumour growth rates, morphology and aggressiveness and may enable treatment to be individualised in a way that is not currently possible.
Rather, the availability of the DCV analysis of the DASH for clinicians and researchers enables the instrument to be individualised to the requirements of a given situation, be that the particular needs of an individual patient or the requirements of a specific research question.
Assessing the quality of performance and reporting of the index standard will be individualised for each test enabling the assessment to look at individual aspects of each test that might introduce bias.
In the curative setting, therefore, there is a need for prognostic markers that can help to stratify patients according to risk, to enable follow-up schedules to be individualised and to tailor eligibility criteria for trials of neo-adjuvant and adjuvant therapies.
With no reported studies investigating hardiness, stress, coping among patients who are required to learn CISC, the study will provide novel information on the association between personality traits and coping abilities, and will, potentially, enable healthcare professionals to individualise CISC training to patient needs.
More data on incidence and reversibility, but moreover earlier indicators of cardiac damage, might in the future enable the necessary level of surveillance to be individualised.
